Currently, in daily clinical practice, breast cancer is classified into two types depending on the expression of the hormone receptor (HR), the human epidermal growth factor receptor 2 (HER2), and the Ki-67 protein in cancer cells. Here, ERBB2 is linked to breast carcinoma.